共 60 条
[1]
Bowles C.A., Vasculopathy associated with the antiphospholipid antibody syndrome, Rheum Dis Clin North Am, 16, pp. 471-480, (1990)
[2]
Alegre V.A., Winkelmann R.K., Histopathologic and immunofluorescence study of skin lesions associated with circulating lupus anticoagulant, J Am Acad Dermatol, 19, pp. 117-124, (1988)
[3]
Alarcon-Segovia D., Cardiel M.H., Reyes E., Antiphospholipid arterial vasculopathy, J Rheumatol, 16, pp. 762-767, (1989)
[4]
Hughson M.D., McCarty G.A., Brumback R.A., Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome, Human Pathol, 26, pp. 716-724, (1995)
[5]
Roubey R.A.S., Mechanisms of autoantibody-mediated thrombosis, Lupus, 7, pp. 114-119, (1998)
[6]
Comp P.C., De B.L.E., Esmon N.L., Et al., Human thrombomodulin is inhibited by IgG from two patients with non-specific anticoagulants [Abstract], Blood, 62, (1983)
[7]
Oosting J.D., Derksen R.H., Bobbink I.W., Et al., Antiphospholipid antibodies directed against a combination of phospholipid with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?, Blood, 81, pp. 2618-2625, (1993)
[8]
Matsuda J., Gohchi K., Kawasugi K., Et al., Inhibitory activity of anti-b2-glycoprotein 1 antibody on factor Va degradation by activated-protein C and its cofactor protein S, Am J Hematol, 49, pp. 89-91, (1995)
[9]
Stankiewickz A.J., Steiner M., Lally E.V., Et al., Abnormally high level of C4b binding protein and deficiency of free fraction of protein S in a patient with systemic lupus erythematosus and recurrent thromboses, J Rheumatol, 18, pp. 82-87, (1991)
[10]
Ruiz-Arguelles G., Ruiz-Arguelles A., Alarcon-Segovia D., Et al., Natural anticoagulants in systemic lupus erythematosus. Deficiency of protein S bound to C4bp associates with recent history of venous thromboses, antiphospholipid antibodies, and the antiphospholipid syndrome, J Rheumatol, 18, pp. 552-558, (1991)